CIK 0000944695
- Large accelerated filer
HANOVER INSURANCE GROUP, INC.
Sign in to watch- Ticker
- THG
- Exchange
- NYSE
- Industry
- Fire, Marine & Casualty Insurance
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043263626
- Phone
- +1 508-855-1000
- Business address
- 440 LINCOLN ST, WORCESTER, MA, 01653
- Former names
- ALLMERICA FINANCIAL CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,989,003
- in 3 filings, $1.9M under 10b5-1 plans
Net −$7,989,003. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-07 | Salvatore Bryan J Executive Vice President | Sale 10b5-1 | −114 | $167.76 | $19K | 25,863.59 |
| 2025-05-07 | Salvatore Bryan J Executive Vice President | Option exercise · Common Stock Option (right to buy) 10b5-1 | −10,526 | 0 | ||
| 2025-04-01 | Roche John C President and CEO | Option exercise 10b5-1 | +8,906 | $77.91 | $694K | 133,319.71 |
| 2025-04-01 | Roche John C President and CEO | Sale 10b5-1 | −8,906 | $175.17 | $1.6M | 124,413.71 |
| 2025-04-01 | Roche John C President and CEO | Option exercise · Common Stock Option (right to buy) 10b5-1 | −8,906 | 0 | ||
| 2025-03-31 | Roche John C President and CEO | Option exercise 10b5-1 | +301 | $77.91 | $23K | 124,714.71 |
| 2025-03-31 | Roche John C President and CEO | Sale 10b5-1 | −301 | $175.00 | $53K | 124,413.71 |
| 2025-03-31 | Roche John C President and CEO | Option exercise · Common Stock Option (right to buy) 10b5-1 | −301 | 8,906 | ||
| 2025-03-28 | LOVELY DAVID JOHN Executive Vice President | Grant or award | +11.69 | 2,254.14 | ||
| 2025-03-28 | Lowsley Denise Executive Vice President | Grant or award | +11.79 | 5,033.82 | ||
| 2025-03-28 | FARBER JEFFREY M Executive Vice President | Grant or award | +50.17 | 45,890.7 | ||
| 2025-03-28 | Lee Willard T Executive Vice President | Grant or award | +12.19 | 5,455.22 | ||
| 2025-03-28 | LAVEY RICHARD W Executive Vice President | Grant or award | +31.44 | 39,079.14 | ||
| 2025-03-28 | Kerrigan Dennis Francis Executive Vice President | Grant or award | +18 | 9,995.59 | ||
| 2025-03-28 | Salvatore Bryan J Executive Vice President | Grant or award | +28.05 | 25,863.59 | ||
| 2025-03-28 | Roche John C President and CEO | Option exercise 10b5-1 | +400 | $77.91 | $31K | 124,677.85 |
| 2025-03-28 | Roche John C President and CEO | Sale 10b5-1 | −400 | $175.03 | $70K | 124,277.85 |
| 2025-03-28 | Roche John C President and CEO | Grant or award 10b5-1 | +135.86 | 124,413.71 | ||
| 2025-03-28 | Roche John C President and CEO | Option exercise · Common Stock Option (right to buy) 10b5-1 | −400 | 9,207 | ||
| 2025-03-27 | Roche John C President and CEO | Option exercise 10b5-1 | +200 | $77.91 | $16K | 124,477.85 |
Page 12 of 18 · 358 trades